IL-17A is a proinflammatory cytokine critical for host defense and involved in the pathogenesis of autoimmune disorders. Obesity is associated with chronic low-grade inflammation but also with a heightened acute inflammatory response. We investigated the effect of obesity on IL-17A production using the model of ZY-induced peritonitis. Compared with lean controls, administration of ZY induced a significantly exacerbated inflammatory response in obese leptin-deficient ob/ob mice and in mice with diet-induced obesity (DIO). Levels of IL-17A in the peritoneal fluid in response to ZY were elevated significantly in ob/ob and DIO mice compared with lean animals. Reconstitution of ob/ob mice with exogenous leptin did not alter production of IL-17A significantly in response to ZY. Peritoneal cells and adipose tissue obtained from ZY-injected obese mice expressed significantly higher levels of IL-17A mRNA compared with lean mice. Approximately 2% of peritoneal Ly6G ϩ neutrophils from ZY-injected obese mice expressed IL-17A protein, compared with 0.2% of cells obtained from lean mice. Neutralization of IL-17 in ob/ob mice inhibited neutrophil recruitment and production of neutrophil-attracting CXC chemokines and IL-6, without affecting macrophage infiltration or levels of IL-10 and the chemokine CCL2. In contrast, neutralization of IL-6 did not affect production of IL-17A or chemokines while reducing production of the acute-phase protein serum amyloid A significantly. These data demonstrate that neutrophil-derived IL-17A is increased in obese mice during acute inflammation and contributes to exacerbation of inflammatory responses.
Introduction
IL-17A, the best-characterized member of the IL-17 family of cytokines, is a potent proinflammatory mediator [1] . In addition to CD4 ϩ Th17 lymphocytes, other cell types, including CD8 ϩ and ␥␦ T cells, NK cells, monocytes, dendritic cells, alveolar macrophages, and neutrophils can produce IL-17A [1] [2] [3] [4] . Although IL-6 and IL-23 play an important role in the differentiation of Th17 cells, the role of these cytokines in inducing production of IL-17A by other cell types has not been investigated fully [1] . IL-17A exerts its inflammatory activities through induction of cytokines, chemokines, and other mediators from several cell types, plays an important role in the pathogenesis of inflammatory, autoimmune, and allergic conditions, and also acts as a pivotal mediator of host defenses against extracellular bacteria [1] .
Obesity is associated with a state of chronic low-grade inflammation, as demonstrated by increased levels of acutephase proteins and proinflammatory mediators in obese compared with lean subjects [5] . In experimental animals, obesity and its proinflammatory phenotype exacerbate disease severity in chronic and acute inflammatory models. In particular, we and others [6 -11] have demonstrated that obesity in mice is associated with increased inflammation and/or delayed resolution in models of acute pancreatitis, endotoxemia, arthritis, exposure to ozone, and neutrophil-mediated peritonitis. Although the association of obesity with high levels of various cytokines, particularly IL-6, TNF-␣, and IL-18, has been widely confirmed [5] , to date only one report investigated the effect of obesity on IL-17, demonstrating the presence of significantly increased circulating levels of IL-17 in obese compared with lean women [12] . However, the mechanisms leading to increased production of IL-17 in obesity, the cell types responsible for its production, as well as the role of IL-17 in the inflammatory response of obesity are currently unknown.
Murine ZY-induced peritonitis is a well-studied model of acute inflammation. We demonstrated previously that obese, leptin-deficient ob/ob mice have an exacerbated and prolonged response to ZY-induced peritoneal inflammation, characterized, among others, by high levels of IL-6 [9] . In the present study, we aimed to evaluate the connection between obesity and IL-17A during ZY-induced peritonitis using two different models of obesity: leptin-deficient ob/ob mice and DIO mice. In DIO mice, obesity, induced by feeding a high-fat diet, is accompanied by hyperleptinemia and hyperglycemia, thus reflecting the hormonal and metabolic conditions present in obese humans. Our hypothesis was that the heightened induc-tion of IL-6 in obese mice in response to ZY would potentiate production of IL-17A, resulting in high levels of this cytokine in obese compared with lean animals. As IL-17A is a potent inducer of neutrophil-attracting CXC chemokines in the peritoneal cavity [13] , we also expected that high levels of IL-17A would mediate the increased neutrophilic infiltrate observed previously in ob/ob mice in response to ZY [9] . In this report, we demonstrate that obesity in mice is associated with increased production of IL-17A in the peritoneal cavity in response to ZY, that neutrophils are the major producers of ZYinduced IL-17A in obese mice, and that IL-17A contributes to potentiating the inflammatory response in obese mice. However, induction of IL-17A in response to ZY in obese animals does not appear to be mediated by IL-6.
MATERIALS AND METHODS

Mice, treatments, and cell culture
Care of mice followed institutional guidelines under a protocol approved by the Institutional Animal Care Committee of the University of Illinois at Chicago (USA). Female and male leptin-deficient ob/ob mice and their lean littermates in a C57BL6 background were obtained from The Jackson Laboratories (Bar Harbor, ME, USA). In separate experiments, male C57BL6 mice were fed a high-fat diet (60 Kcal % fat; Research Diets, New Brunswick, NJ, USA) for 16 weeks. Obesity was verified by measurement of body weight and evaluation of fat mass by whole-body DEXA. Mice received an i.p. injection of ZY (Sigma Chemical Co., St. Louis, MO, USA) at 100 mg/kg or vehicle (PBS). In some experiments, mice received a neutralizing anti-IL-17 or anti-IL-6 antibody (1 mg/mouse; Biolegend, San Diego, CA, USA) or the same amount of unspecific IgG as a control. For leptin reconstitution experiments, ob/ob mice received twice-daily i.p. injections of recombinant murine leptin (R&D Systems, Minneapolis, MN, USA) at 1 mg/kg for 5 days prior to ZY administration, as described previously [9] .
Mice were killed by cervical dislocation under isoflurane anesthesia at various times after treatment. Blood was obtained from the retro-orbital plexus, and the peritoneal cavity was lavaged with 5 ml ice-cold RPMI containing 1% penycillin/streptomycin to obtain PLF. Peritoneal cells were counted and cultured overnight at 4 ϫ 10 6 /ml at 37°C in 96-well plates in the presence or absence of in vitro restimulation with ZY (10 g/ml). In some experiments, cells were cultured in the presence or absence of the same neutralizing anti-IL-6 antibody used for in vivo studies at 10 g/ml or unspecific IgG.
Purification of peritoneal neutrophils
Peritoneal cells obtained from five lean, DIO and ob/ob ZY-injected mice were pooled and neutrophils were positively selected using the anti-Ly-6G MicroBead kit from Miltenyi Biotec (Auburn, CA, USA). The enriched population was Ͼ98% pure as evaluated by flow cytometry.
Flow cytometry analysis
To characterize the cell types producing IL-17A, total peritoneal cells from ZY-injected mice as well as the neutrophil population purified as described above were cultured for 4 h at 4 ϫ 10 6 /ml at 37°C in the presence of monensin. Cells were analyzed by flow cytometry using a FACSCalibur (BD Biosciences, San Jose, CA, USA) following surface staining with FITC-conjugated antibodies directed against Ly6G, CD4 or TCR ␥␦ and intracellular staining with a PE-conjugated anti-IL-17A antibody or PE-conjugated unspecific IgG as a control. Antibodies were obtained from eBioscience (San Diego, CA, USA) and BD Biosciences.
Miscellaneous measurements
Levels of leptin and the cytokines IL-17A, IL-6, IL-10, TNF-␣, IFN-␥, CXCL1, CXCL2, and CCL2 were measured by ELISA using kits from R&D Systems. SAA was measured using a kit from Invitrogen (Carlsbad, CA, USA). Blood glucose levels were measured using the One-Touch glucose monitoring system (LifeScan, Inc., Milpitas, CA, USA).
Quantitative RT-PCR
Total RNA was extracted from peritoneal cells, purified neutrophils, visceral perigonadal adipose tissue, and spleen and reverse-transcribed. Quantitative RT-PCR was performed using primers specific for murine IL-17A (Mm00439619_m1) obtained from Applied Biosystems (Foster City, CA, USA) and the TaqMan system. Data normalized to GAPDH were compared using the ⌬⌬ comparative threshold method and expressed as fold induction of gene expression over vehicle-injected lean mice.
Statistical analysis
Data are expressed as mean Ϯ sem. Statistical significance of differences between treatment and control groups was determined by factorial ANOVA. Statistical analysis was performed using the XLStat software (Addinsoft, Brooklyn, NY, USA).
RESULTS
Inflammatory infiltrate and cytokine levels in obese mice receiving ZY
In the present study, we evaluated the effect of obesity on the response to ZY injection using two models of obesity: leptindeficient ob/ob mice, a model of genetically induced obesity; and mice in which obesity was induced by feeding a high-fat diet (DIO). As indicated in Table 1 , significantly higher body weight, fat mass, and fasting glycemia were observed in DIO and ob/ob mice compared with lean controls, whereas as expected, leptin was undetectable in ob/ob mice and significantly higher in DIO mice compared with lean animals.
We demonstrated previously that ob/ob mice develop a more severe and prolonged inflammatory response compared with lean mice following administration of ZY [9] . The exacerbated response of ob/ob mice is characterized by a significantly higher inflammatory infiltrate in the peritoneal cavity as well as increased levels of IL-6, TNF-␣, and chemokines [9] . As indicated in Table 2 and in agreement with our previous results, administration of ZY induced a significantly heightened inflammatory infiltrate associated with significantly higher levels of IL-6, TNF-␣, and CXCL2 in the peritoneal cavity in ob/ob compared with lean mice. A significantly enhanced inflammatory outcome in response to ZY administration was also observed in DIO mice ( Table 2 ), indicating that DIO and genetically induced obesity are associated with an exacerbated acute response to ZY.
Increased levels of IL-17A in obese mice in response to ZY
To study the effect of obesity on IL-17A production, levels of IL-17A were measured in the PLF and serum at various timepoints after ZY administration in lean, ob/ob, and DIO mice. As shown in Figure 1A , a transient, nonsignificant induction of IL-17A was observed at 6 h in the PLF of lean mice. In contrast, ob/ob and DIO mice had a significantly magnified and prolonged production of IL-17A in response to ZY. As shown in Figure 1B , administration of exogenous leptin using a dose and schedule shown previously to modulate production of TNF-␣ and CXCL2 [9] did not alter induction of IL-17A significantly in ob/ob mice after ZY administration. Serum IL-17 levels remained below detection limit in lean, DIO, and ob/ob mice at each time-point evaluated (data not shown). In mice, IL-6 and IL-23 are important cytokines for production of IL-17 by T cells [1] . Levels of IL-6 were elevated significantly in DIO and ob/ob compared with lean mice 24 h after ZY administration in PLF (see Table 2 ) and serum (0.06Ϯ0.02, 5.1Ϯ0.6, and 4.5Ϯ2.1 ng/ml in lean, DIO, and ob/ob mice, respectively; nϭ5; PϽ0.001 DIO or ob/ob vs. lean). In contrast, IL-23 levels remained below the detection limit in PLF and serum at each time-point analyzed (0, 2, 6, and 24 h post-ZY) in each group (data not shown). The Th1 cytokine IFN-␥ is a strong inhibitor of IL-17A production, and leptin is a Th1-skewing adipokine [1, 14] . Therefore, we compared IFN-␥ levels in lean and obese mice in response to ZY. Data presented in Table 2 indicate that administration of ZY did not increase IFN-␥ levels in lean mice, whereas a significant induction was observed in DIO and ob/ob mice at 24 h. Collectively, these data indicate that obese mice produce significantly higher levels of IL-17A compared with lean mice in response to ZY; IL-17A production is prolonged in obese mice receiving ZY; reconstitution with exogenous leptin does not alter IL-17A levels significantly in ZY-injected ob/ob mice; and increased and prolonged production of IL-17A in obese mice is associated with high levels of IL-6, lack of induction of IL-23, and increased production of IFN-␥ compared with lean mice.
Tissue and cellular origin of IL-17A in response to ZY
To identify the cellular source of IL-17A in obese mice receiving ZY, cells infiltrating the peritoneal cavity, visceral adipose tissue, and the spleen were collected at 6 and 24 h after administration of ZY or at 24 h after vehicle injection from lean and ob/ob mice. Quantitative RT-PCR analysis indicated that cells infiltrating the peritoneal cavity expressed high levels of IL-17A mRNA in ob/ob mice in response to ZY, whereas only a minor, nonsignificant induction of IL-17A expression was observed in peritoneal cells obtained from lean animals receiving ZY ( Fig. 2A) . Comparable results were obtained using peritoneal cells obtained from ZY-injected DIO mice, in which the relative increase in IL-17A mRNA expression 24 h after ZY administration was 1734 Ϯ 623 compared with cells obtained from ZY-injected lean mice (nϭ7; meanϮsem).
A significant induction of IL-17 mRNA expression was also observed in adipose tissue obtained from ZY-injected ob/ob mice but not from lean mice (Fig. 2B) , suggesting that cellular components of adipose tissue actively produce this cytokine in ZY-injected obese mice. Expression of IL-17A remained below detection limit in splenocytes of lean and obese mice at each time-point examined after ZY administration (data not shown).
As obese mice have a significantly higher inflammatory infiltrate compared with lean animals in response to ZY (see Table  2 and ref. [9] ), it was important to discriminate whether obesity leads to enhanced production of IL-17A on a per-cell basis or, alternatively, the higher levels of IL-17A present in the PLF of obese mice are secondary to the increased cellular infiltrate. To discriminate between these two possibilities, peritoneal cells obtained from lean and ob/ob mice that had received ZY 24 h earlier were cultured overnight at the same cellular density (4ϫ10 6 /ml), with and without in vitro restimulation with ZY. As shown in Figure 2C , cells obtained from ob/ob mice produced significantly higher levels of IL-17A on a per-cell basis To identify the cell types producing IL-17A specifically in obese mice, peritoneal cells obtained from ZY-injected lean and DIO mice were analyzed by flow cytometry. As shown in Figure 3A , 2.1% of Ly6G ϩ neutrophils obtained from ZY-injected DIO mice were positive for IL-17A, whereas only 0.2% of Ly6G ϩ cells obtained from ZY-injected lean mice expressed IL-17A. Production of IL-17A by neutrophils in obese mice was also confirmed after purification of Ly6G ϩ cells over magnetic beads (Fig. 3C) . In this population, composed of Ͼ98% Ly6G To verify whether CD4 ϩ T cells contribute to IL-17A production in ZY-injected obese mice, peritoneal cells were costained for CD4 and IL-17A. As shown in Figure 3B , the peritoneal infiltrate obtained 6 h after ZY contained Ͻ2% CD4 ϩ cells in lean and DIO mice following administration of ZY, and these CD4 ϩ cells did not coexpress IL-17A. Furthermore, the peritoneal infiltrate contained Ͻ2% TCR ␥␦ T cells at 6 h after ZY in lean and obese mice, and these cells also did not coexpress IL-17A (data not shown). As a result of the low numbers of CD4 ϩ cells present in the peritoneal cavity of ZYinjected mice, we were unable to enrich a population of CD4 
Effect of IL-17 neutralization on ZY-induced inflammation in ob/ob mice
Through its ability to induce production of chemokines, IL-17 is responsible for mediating a neutrophilic infiltrate in response to a variety of stimuli [1] . To evaluate whether increased levels of IL-17A are responsible for the enhanced and prolonged inflammatory infiltrate of obese mice, animals were injected with ZY, with and without a neutralizing anti-IL-17 antibody [15] . As shown in Figure 4A , neutralization of IL-17 normalized the neutrophilic infiltrate of ob/ob mice to the level of lean mice at 24 h and reduced it significantly at 48 h. However, as shown in Figure 4B , neutralization of IL-17 did not alter the number of F4/80 ϩ macrophages infiltrating the peritoneal cavity of ob/ob mice. The selective effect of IL-17 on neutrophils was likely mediated by the ability of this cytokine to induce production of CXC chemokines [1] . In fact, as shown in Figure 4 , C-E, neutralization of IL-17 inhibited peritoneal levels of the neutrophil-attracting chemokines CXCL1 and CXCL2 in ob/ob mice without affecting production of CCL2, a monocyte-attracting chemokine.
As IL-17 and IL-6 induce each other reciprocally in T lymphocytes [1] , we evaluated the effect of IL-17 neutralization on the enhanced production of IL-6 of ob/ob mice. As shown in Figure 4F , treatment with anti-IL-17 antibody reduced IL-6 levels significantly in ob/ob mice. However, this was not a generalized effect, as IL-10 -whose production is not increased in ob/ob mice in response to ZY, as we demonstrated recently [9] -was not affected by neutralization of IL-17 (Fig. 4G) .
Effect of IL-6 neutralization on production of IL-17A in ob/ob mice As IL-6 is an important IL-17-inducing cytokine, we investigated the specific role of IL-6 in the enhanced IL-17A response of ob/ob mice during ZY-induced peritonitis by administering a neutralizing anti-IL-6 antibody [15, 16] . Neutralization of IL-6 did not alter IL-17A levels significantly in the PLF of ob/ob mice (Fig. 5A) . Furthermore, when cultured in vitro overnight, peritoneal cells obtained from ob/ob mice that had received the anti-IL-6 antibody in vivo produced levels of IL-17A comparable with those of mice receiving unspecific IgG (Fig. 5B) levels significantly in ZY-injected mice (Fig. 5C) . Thus, whereas neutralization of IL-17A reduces IL-6 production significantly in ob/ob mice (see Fig. 4F ), the reciprocal was not observed, as neutralization of IL-6 did not alter IL-17A levels in response to ZY in ob/ob mice.
DISCUSSION
In the present report, we demonstrate that obese ob/ob and DIO mice produce significantly higher levels of IL-17A compared with their lean littermates during ZY-induced peritonitis and that obesity is associated with prolonged production of IL-17A. As ob/ob mice are obese because they lack leptin, an adipokine with major effects on the immune/inflammatory response [17] , it was important to evaluate whether obesity per se or leptin deficiency is responsible for the increased levels of IL-17A in ZY-injected ob/ob mice. Our data demonstrate that administration of exogenous leptin, using a dose and schedule previously shown to alter inflammatory responses significantly [9, 18, 19] , did not inhibit production of IL-17A in response to ZY in ob/ob mice. These results, together with the observation that DIO mice, which are hyperleptinemic, also produce high levels of IL-17A when injected with ZY, indicate that excess adiposity is responsible for the enhanced production of IL-17A in obese mice. Our results are in agreement with a report demonstrating increased systemic levels of IL-17 in obese women, who have high levels of leptin, compared with lean subjects [12] .
Although production of IL-17A by CD4 ϩ lymphocytes has been the focus of extensive research, considerable evidence also indicates that other cell types produce this cytokine in response to a variety of stimuli [2, 3, 20, 21] . The model of ZY-induced peritonitis is characterized by a marked neutrophilic infiltrate, and our data indicate that ϳ2% of infiltrating neutrophils produce IL-17A in response to ZY administration in obese mice. We also found that purified peritoneal neutrophils obtained from ZY-injected obese mice expressed higher levels of IL-17A mRNA compared with neutrophils from lean animals. Our results confirm previous observations indicating that neutrophils express IL-17 mRNA and protein under various types of stimulations, such as administration of endotoxin, complement activation or experimental leishmaniasis [20 -22] . These previous reports, together with our present data, indicate that neutrophils are an important source of IL-17A during activation of the innate immune response. Our data also suggest that CD4 ϩ lymphocytes and TCR ␥␦ T cells are not major contributors to production of IL-17A in obese mice receiving ZY. In fact, we were unable to demonstrate IL-17A production from CD4 ϩ or TCR ␥␦ T cells, which represented Ͻ2% of infiltrating cells in the peritoneal cavity of lean and obese mice receiving ZY. However, as a result of technical difficulties in isolating a sufficiently pure population of CD4 ϩ cells from ZY-injected mice, we were unable to rule out definitely the possibility that CD4 ϩ lymphocytes might express IL-17A mRNA in response to ZY. Therefore, we cannot exclude that more sensitive methods of detection would implicate lymphocytes as contributing to IL-17A production in response to ZY.
Visceral adipose tissue obtained from obese animals expressed IL-17A after administration of ZY, although at lower levels compared with the peritoneal inflammatory infiltrate. That adipose tissue is an active participant in the inflammatory response and contributes to obesity-associated pathologies has been demonstrated amply [23] . Our data indicate that IL-17A is part of the armamentarium of inflammatory mediators produced by adipose tissue, as also suggested by data indicating that IL-17A induces production of IL-6, IL-8, and cyclooxygenase-2 and increases lipolysis in differentiated adipocytes [24] . Future studies will be aimed at investigating the specific source and role of adipose tissue-derived IL-17A and its connection with the chronic inflammation of obesity.
Although the cytokine milieu responsible for differentiation of Th17 cells has been evaluated in detail, factors leading to production of IL-17A in response to inflammatory stimuli have not been investigated extensively. In mice, the most important cytokine for differentiation of Th17 cells is IL-6, and IL-23 also plays an important role in enhancing synthesis of IL-17A further [1] . At the same time, IL-17A induces production of IL-6 by inflammatory cells and adipocytes [24, 25] , thus reinforcing the presence of a proinflammatory loop between IL-6 and IL-17A. Our data demonstrate that IL-17 contributes to the heightened production of IL-6 in response to ZY in obese mice. In fact, neutralization of IL-17 suppressed the enhanced IL-6 production of ob/ob mice, restoring IL-6 to levels comparable with those observed in lean mice. In contrast, anti-IL-6 antibodies did not inhibit production of IL-17A in response to ZY, although they suppressed induction of SAA significantly, demonstrating their effectiveness in neutralizing IL-6 bioactivity. When analyzed together, these data indicate that IL-17A plays a prominent role in enhancing IL-6 production during neutrophil-mediated inflammation in obesity, whereas IL-6 does not appear to influence IL-17A production under these conditions. Data from the ZY model also indicate that IL-23 is likely not involved in the induction of IL-17A in obese mice in response to ZY, as IL-23 levels remained undetectable in lean and obese animals. Furthermore, exacerbated production of IL-17A in obese mice was not secondary to reduced levels of IFN-␥, an important inhibitor of IL-17A synthesis [1, 25] . In fact, an increased, rather than suppressed, production of IFN-␥ was observed in ob/ob and DIO mice receiving an injection of ZY, thus excluding reduced IFN-␥ levels as a potential contributor to the high IL-17A response of obese mice. The exact mediators responsible for increased production of IL-17A in obese mice remain to be identified and potentially include activation of complement, which is increased in obesity [26] and can induce production of IL-17 by neutrophils [20] .
Not only do obese mice produce high levels of IL-17A, but this cytokine is an active participant in the exacerbated inflammatory response to ZY of ob/ob animals. In fact, neutralization of IL-17 activity in ob/ob mice led to a significant reduction in the neutrophilic infiltrate in response to ZY, secondary to inhibition of neutrophil-attracting CXC chemokines. In agreement with the role of IL-17 as a selective inducer of CXC chemokines [1] , neutralization of IL-17 did not affect macrophage infiltration or production of CC chemokines in ob/ob mice. Thus, IL-17 plays a selective role in specifically exacerbating the neutrophilic response of ob/ob mice, in agreement with data obtained using a model of endotoxin-induced lung inflammation [21] . Furthermore, as discussed above, early production of IL-17A is an important factor in inducing and maintaining high levels of IL-6 in obese mice in response to ZY. These data indicate that production of IL-17A in the course of acute inflammation in obese mice plays a critical pathological role by exacerbating the neutrophilic influx and enhancing IL-6 production, thus feeding into a positive loop that prolongs inflammation and acute-phase responses and delays resolution.
In summary, our data demonstrate that obesity leads to increased and prolonged production of the proinflammatory cytokine IL-17A in a model of acute peritonitis and that IL-17A produced under these conditions plays a prominent role in orchestrating the exacerbated inflammatory response of obese mice. These observations implicate IL-17A as an important cytokine, whose production is deregulated in obesity, and open new avenues in the investigation of the potential connection among obesity, IL-17A, and inflammation.
